Table 1B.

Baseline Pulmonary Function Data

VariableBudesonide Nebulizing Suspension
Placebo0.25 mg
QD
0.25 mg
BID
0.5 mg
BID
1.0 mg
QD
Total
n9594999895481
PFT Able*
n(%)32 (34)33 (35)34 (34)30 (31)35 (37)164 (34)
FEV1 (L)1.2 (0.3)1.2 (0.3)1.2 (0.3)1.2 (0.3)1.1 (0.2)1.2 (0.3)
 % Predicted (±SD)79 (17)79 (17)83 (20)80 (21)78 (14)80 (18)
 % Reversibility (±SD)29 (18)29 (15)30 (17)30 (19)27 (12)29 (16)
Morning PEF (L/min)
 Mean (±SD)156 (38)164 (54)157 (34)167 (49)157 (41)160 (43)
Evening PEF (L/min)
 Mean (±SD)161 (37)170 (52)169 (36)177 (54)166 (36)168 (43)
  • * Patient able to perform spirometry and peak flow.

  • Percent of predicted value for age, height, and gender (20).